Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Sensorineural hearing loss in patients with head and neck cancer after chemoradiotherapy and radiotherapy: a systematic review of the literature.

Theunissen EA, Bosma SC, Zuur CL, Spijker R, van der Baan S, Dreschler WA, de Boer JP, Balm AJ, Rasch CR.

Head Neck. 2015 Feb;37(2):281-92. doi: 10.1002/hed.23551. Epub 2014 Jan 29. Review.

PMID:
24478269
2.

Cochlea CT radiomics predicts chemoradiotherapy induced sensorineural hearing loss in head and neck cancer patients: A machine learning and multi-variable modelling study.

Abdollahi H, Mostafaei S, Cheraghi S, Shiri I, Rabi Mahdavi S, Kazemnejad A.

Phys Med. 2018 Jan;45:192-197. doi: 10.1016/j.ejmp.2017.10.008. Epub 2018 Jan 10.

PMID:
29329660
3.

Relative contributions of radiation and cisplatin-based chemotherapy to sensorineural hearing loss in head-and-neck cancer patients.

Hitchcock YJ, Tward JD, Szabo A, Bentz BG, Shrieve DC.

Int J Radiat Oncol Biol Phys. 2009 Mar 1;73(3):779-88. doi: 10.1016/j.ijrobp.2008.05.040. Epub 2008 Aug 15.

PMID:
18707819
4.

[Ototoxicity in head and neck cancers after radiotherapy and chemoradiotherapy: From primary prevention to tertiary prevention].

Espenel S, Garcia MA, Guy JB, Vallard A, Ben Mrad M, Langrand-Escure J, El Meddeb Hamrouni A, Trone JC, Xia Y, Rancoule C, Magné N.

Cancer Radiother. 2017 Feb;21(1):77-83. doi: 10.1016/j.canrad.2016.08.130. Epub 2017 Feb 8. French.

PMID:
28189351
5.

Sensorineural hearing loss after treatment of nasopharyngeal carcinoma: a longitudinal analysis.

Chan SH, Ng WT, Kam KL, Lee MC, Choi CW, Yau TK, Lee AW, Chow SK.

Int J Radiat Oncol Biol Phys. 2009 Apr 1;73(5):1335-42. doi: 10.1016/j.ijrobp.2008.07.034. Epub 2008 Oct 14.

PMID:
18922648
6.

Short-term cohort study on sensorineural hearing changes in head and neck radiotherapy.

Cheraghi S, Nikoofar P, Fadavi P, Bakhshandeh M, Khoie S, Gharehbagh EJ, Farahani S, Mohebbi A, Vasheghani M, Zare M, Nikoofar A, Mahdavi SR.

Med Oncol. 2015 Jul;32(7):200. doi: 10.1007/s12032-015-0646-3. Epub 2015 Jun 13.

PMID:
26071124
7.

Ototoxicity in a randomized phase III trial of intra-arterial compared with intravenous cisplatin chemoradiation in patients with locally advanced head and neck cancer.

Zuur CL, Simis YJ, Lansdaal PE, Hart AA, Schornagel JH, Dreschler WA, Rasch CR, Balm AJ.

J Clin Oncol. 2007 Aug 20;25(24):3759-65.

PMID:
17704425
8.

Impact of radiation technique, radiation fraction dose, and total cisplatin dose on hearing : Retrospective analysis of 29 medulloblastoma patients.

Scobioala S, Parfitt R, Matulat P, Kittel C, Ebrahimi F, Wolters H, Am Zehnhoff-Dinnesen A, Eich HT.

Strahlenther Onkol. 2017 Nov;193(11):910-920. doi: 10.1007/s00066-017-1205-y. Epub 2017 Sep 8.

PMID:
28887665
9.

Characteristics of radiation-induced sensorineural hearing loss in head and neck cancer: a systematic review.

Mujica-Mota M, Waissbluth S, Daniel SJ.

Head Neck. 2013 Nov;35(11):1662-8. doi: 10.1002/hed.23201. Epub 2012 Dec 22. Review.

PMID:
23280686
10.

Long-term outcome of sensorineural hearing loss in nasopharyngeal carcinoma patients: comparison between treatment with radiotherapy alone and chemoradiotherapy.

Wei Y, Zhou T, Zhu J, Zhang Y, Sun M, Ding X, Wang D, Li H, Li B.

Cell Biochem Biophys. 2014 Jul;69(3):433-7. doi: 10.1007/s12013-014-9814-x.

PMID:
24510513
11.

Prediction of Hearing Loss Due to Cisplatin Chemoradiotherapy.

Theunissen EA, Zuur CL, Józwiak K, Lopez-Yurda M, Hauptmann M, Rasch CR, van der Baan S, de Boer JP, Dreschler WA, Balm AJ.

JAMA Otolaryngol Head Neck Surg. 2015 Sep;141(9):810-5. doi: 10.1001/jamaoto.2015.1515.

PMID:
26291150
12.

Risk factors of ototoxicity after cisplatin-based chemo-irradiation in patients with locally advanced head-and-neck cancer: a multivariate analysis.

Zuur CL, Simis YJ, Lansdaal PE, Hart AA, Rasch CR, Schornagel JH, Dreschler WA, Balm AJ.

Int J Radiat Oncol Biol Phys. 2007 Aug 1;68(5):1320-5. Epub 2007 Apr 6.

PMID:
17418969
13.

Ototoxic effects of supradose cisplatin with sodium thiosulfate neutralization in patients with head and neck cancer.

Madasu R, Ruckenstein MJ, Leake F, Steere E, Robbins KT.

Arch Otolaryngol Head Neck Surg. 1997 Sep;123(9):978-81.

PMID:
9305250
14.

Sensorineural hearing loss in combined modality treatment of nasopharyngeal carcinoma.

Chen WC, Jackson A, Budnick AS, Pfister DG, Kraus DH, Hunt MA, Stambuk H, Levegrun S, Wolden SL.

Cancer. 2006 Feb 15;106(4):820-9.

15.

Hearing and tinnitus in head and neck cancer patients after chemoradiotherapy.

Niemensivu R, Saarilahti K, Ylikoski J, Aarnisalo A, Mäkitie AA.

Eur Arch Otorhinolaryngol. 2016 Sep;273(9):2509-14. doi: 10.1007/s00405-015-3857-5. Epub 2015 Dec 21.

PMID:
26685859
16.

Audiometric patterns in ototoxicity of intra-arterial Cisplatin chemoradiation in patients with locally advanced head and neck cancer.

Zuur CL, Simis YJ, Lansdaal PE, Rasch CR, Tange RA, Balm AJ, Dreschler WA.

Audiol Neurootol. 2006;11(5):318-30. Epub 2006 Sep 18.

PMID:
16983183
17.

Cytogenetic damage of radiotherapy in long-term head and neck cancer survivors.

Unal D, Kiraz A, Avci D, Tasdemir A, Unal TD, Cagli S, Eroglu C, Yuce I, Ozcan I, Kaplan B.

Int J Radiat Biol. 2016 Jul;92(7):364-70. doi: 10.1080/09553002.2016.1175680. Epub 2016 Apr 26.

PMID:
27113979
18.

Sensorineural hearing loss after radiotherapy for head and neck tumors: a prospective study of the effect of radiation.

Yilmaz YF, Aytas FI, Akdogan O, Sari K, Savas ZG, Titiz A, Tumoz M, Unal A.

Otol Neurotol. 2008 Jun;29(4):461-3. doi: 10.1097/MAO.0b013e31816c7c9e.

PMID:
18520582
19.

Audiological profile of patients treated for childhood cancer.

Liberman PH, Goffi-Gomez MV, Schultz C, Novaes PE, Lopes LF.

Braz J Otorhinolaryngol. 2016 Nov - Dec;82(6):623-629. doi: 10.1016/j.bjorl.2015.11.021. Epub 2016 Apr 13.

20.

Induction chemotherapy with docetaxel/cisplatin/5-fluorouracil followed by randomization to two cisplatin-based concomitant chemoradiotherapy schedules in patients with locally advanced head and neck cancer (CONDOR study) (Dutch Head and Neck Society 08-01): A randomized phase II study.

Driessen CM, de Boer JP, Gelderblom H, Rasch CR, de Jong MA, Verbist BM, Melchers WJ, Tesselaar ME, van der Graaf WT, Kaanders JH, van Herpen CM.

Eur J Cancer. 2016 Jan;52:77-84. doi: 10.1016/j.ejca.2015.09.024. Epub 2015 Dec 1.

Supplemental Content

Support Center